These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1480955)

  • 61. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Physician Bayesian updating from personal beliefs about the base rate and likelihood ratio.
    Rottman BM
    Mem Cognit; 2017 Feb; 45(2):270-280. PubMed ID: 27752962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The causal diagnosis of obstructive jaundice. A Bayesian approach.
    Jovin GH; Vasilescu C; Popescu I; Cizmaş P
    Med Interne; 1988; 26(3):213-20. PubMed ID: 3055242
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The potential of clustering methods to define intersection test scenarios: Assessing real-life performance of AEB.
    Sander U; Lubbe N
    Accid Anal Prev; 2018 Apr; 113():1-11. PubMed ID: 29355748
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Probabilistic sensitivity analysis: be a Bayesian.
    Boshuizen HC; van Baal PH
    Value Health; 2009; 12(8):1210-4. PubMed ID: 19695002
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A procedure for investigating cancer cluster reports.
    Aldrich TE
    Med Hypotheses; 1981 Jun; 7(6):809-17. PubMed ID: 7278738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The value of Bayes' theorem for pure likelihood clinical reasoning.
    Phelan PS
    J Eval Clin Pract; 2018 Aug; 24(4):782-783. PubMed ID: 29761592
    [No Abstract]   [Full Text] [Related]  

  • 69. Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach.
    Stopka TJ; Goulart MA; Meyers DJ; Hutcheson M; Barton K; Onofrey S; Church D; Donahue A; Chui KKH
    BMC Infect Dis; 2017 Apr; 17(1):294. PubMed ID: 28427355
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluating geostatistical modeling of exceedance probability as the first step in disease cluster investigations: very low birth weights near toxic Texas sites.
    Thompson JA; Bissett WT; Sweeney AM
    Environ Health; 2014 Jun; 13(1):47. PubMed ID: 24906417
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Things to know and do about cancer clusters.
    Aldrich T; Sinks T
    Cancer Invest; 2002; 20(5-6):810-6. PubMed ID: 12206154
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating causation in cancer clusters.
    Heath CW
    Radiat Environ Biophys; 1996 Aug; 35(3):133-6. PubMed ID: 8880953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer clusters: a myth or a method.
    Aldrich TE; Garcia N; Ziechner S; Berger S
    Med Hypotheses; 1983 Sep; 12(1):41-52. PubMed ID: 6646010
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimating statistical power, posterior probability and publication bias of psychological research using the observed replication rate.
    Ingre M; Nilsonne G
    R Soc Open Sci; 2018 Sep; 5(9):181190. PubMed ID: 30839704
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methodological problems in investigating disease clusters.
    Wartenberg D; Greenberg M
    Sci Total Environ; 1992 Dec; 127(1-2):173-85. PubMed ID: 1480954
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Response to Condon et al. comments on "Cancer clusters in the USA: what do the last twenty years of state and federal investigations tell us?".
    Goodman M; Naiman JS; Goodman D; LaKind JS
    Crit Rev Toxicol; 2013 Jan; 43(1):75-6. PubMed ID: 23151122
    [No Abstract]   [Full Text] [Related]  

  • 77. Analysis of spatial aggregation.
    Smans M
    Recent Results Cancer Res; 1989; 114():83-6. PubMed ID: 2813946
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Commentary: Assessment of chance should be central in investigation of cancer clusters.
    Lawson AB
    Int J Epidemiol; 2013 Apr; 42(2):448-9; discussion 455-6. PubMed ID: 23569184
    [No Abstract]   [Full Text] [Related]  

  • 79. Time for a change.
    Wilson JD
    Risk Anal; 1986 Jun; 6(2):111-2. PubMed ID: 3615983
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.